Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,120.46
(
0.80%
)
US TECH 100
26,103.60
(
1.28%
)
Dow Jones
49,478.72
(
0.67%
)
Brent Oil
97.26
(
2.36%
)
Bitcoin
78,983.58
(
3.48%
)
News Focus
News Focus
Post# of 257437
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 843
Posts 122881
Boards Moderated 9
Alias Born 09/05/2002

DewDiligence

Member Level

Re: Biowatch post# 46151

Thursday, 07/19/2007 10:39:34 PM

Thursday, July 19, 2007 10:39:34 PM

Post# of 257437
No more foul tips for GNTA in Europe…

http://www.reuters.com/article/topNews/idUKWLB912020070719?rpc=44

>>
EU Panel Gives Final No to Genasense

Thu Jul 19, 2007 1:57PM EDT

LONDON, July 19 (Reuters) - The European Medicines Agency said on Thursday it had adopted a final negative opinion on Genta's (GNTA) metastatic melanoma drug Genasense.

"Following the re-examination of the negative opinion adopted on 26 April 2007, the CHMP confirmed its previous position and adopted a final negative opinion for Genasense," a committee of experts at the European Medicines Agency said in a statement.
<<

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today